Swiss Healthtech Stock News

As European markets experience a positive upswing, with the STOXX Europe 600 Index rising by 2.35%, investors are keenly observing the region's economic landscape, particularly as inflation appears to align closely with the European Central Bank’s target. In this context, dividend stocks can offer attractive opportunities for income-focused investors seeking stability and potential growth in a market characterized by subdued inflation and strategic fiscal adjustments.

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Alcon's (VTX:ALC) stock is up by a considerable 6.6% over the past month. We wonder if and what role the company's...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

While Bachem Holding AG ( VTX:BANB ) might not have the largest market cap around , it received a lot of attention from...

Key Insights Using the 2 Stage Free Cash Flow to Equity, SFS Group fair value estimate is CHF178 SFS Group is estimated...

Key Insights Significantly high institutional ownership implies Vontobel Holding's stock price is sensitive to their...

Unfortunately for some shareholders, the Leclanché SA ( VTX:LECN ) share price has dived 26% in the last thirty days...

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Ideally, a...

When we're researching a company, it's sometimes hard to find the warning signs, but there are some financial metrics...

Despite an already strong run, Newron Pharmaceuticals S.p.A. ( VTX:NWRN ) shares have been powering on, with a gain of...

Amid renewed worries about inflated AI stock valuations and receding expectations for a U.S. interest rate cut, European markets have experienced a downturn, with the pan-European STOXX Europe 600 Index ending 2.21% lower. Despite this challenging environment, opportunities may exist in stocks that are priced below their estimated value, offering potential for investors who focus on fundamental strengths such as solid business models and sustainable growth prospects.

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

medmix AG's ( VTX:MEDX ) price-to-sales (or "P/S") ratio of 0.8x may look like a very appealing investment opportunity...

PolyPeptide Group AG's ( VTX:PPGN ) price-to-sales (or "P/S") ratio of 2.4x might make it look like a buy right now...

SHL Telemedicine Ltd. ( VTX:SHLTN ) shareholders are no doubt pleased to see that the share price has bounced 31% in...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...

Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...

On November 18, 2025, u-blox Holding AG (SWX:UBXN) was removed from the S&P Global BMI Index, a widely tracked global benchmark for equities. This index exclusion can influence trading behavior, as passive funds often adjust their portfolios to align with index changes, potentially impacting liquidity. We'll now consider how the index removal and subsequent fund adjustments may shape u-blox Holding's broader investment narrative. We've found 15 US stocks that are forecast to pay a dividend...

Key Insights Given the large stake in the stock by institutions, Landis+Gyr Group's stock price might be vulnerable to...

The last three months have been tough on ARYZTA AG ( VTX:ARYN ) shareholders, who have seen the share price decline a...

Shareholders might have noticed that Swiss Re AG ( VTX:SREN ) filed its third-quarter result this time last week. The...

Earlier this month, SKAN Group AG issued a profit warning for 2025 after a portfolio review revealed several project delays, resulting in lowered earnings and sales guidance for the current financial year. Despite the near-term challenges, SKAN reiterated its medium-term targets and highlighted a robust order intake that is expected to drive a strong rebound in 2026. We’ll examine how SKAN’s revised 2025 outlook and order backlog developments impact the longer-term investment case for the...